NVG-291 is a synthetic research peptide investigated for its potential interaction with pathways involved in neuronal signaling, tissue regeneration, and cellular adaptation. Experimental studies focus on its ability to modulate signaling environments that influence cell growth, structural remodeling, and communication between cells, particularly within the nervous system. By targeting mechanisms related to cellular repair and extracellular matrix dynamics, NVG-291 is explored in research contexts examining neural plasticity, tissue recovery, and response to cellular stress. Its relevance lies in its potential to influence multiple interconnected biological processes rather than a single isolated pathway.

Orexin-A is a neuropeptide that has been extensively studied for its role in the regulation of wakefulness and arousal. Research has also explored its involvement in pathways related to appetite regulation, locomotor activity, and autonomic nervous system signaling, including modulation of sympathetic tone. These findings highlight the importance of Orexin-A in maintaining physiological balance across sleep–wake cycles and energy-related processes.

Orexin-A (Hypocretin-1) is a neuropeptide derived from the lateral hypothalamus and plays a central role in sleep–wake regulation, arousal stability, and autonomic balance. It interacts with orexin receptors OXR1 and OXR2 and modulates key neurotransmitter systems including dopamine, norepinephrine, serotonin, and histamine. Experimental research has examined Orexin-A in models of narcolepsy, sleep–wake dysregulation, neuroinflammation, thermoregulation, and autonomic control. Due to its ability to cross the blood–brain barrier, Orexin-A remains a molecule of interest in central nervous system signaling research. Orexin-B (Hypocretin-2) is a hypothalamic neuropeptide primarily interacting with the orexin receptor OXR2, contributing to sleep–wake homeostasis and arousal regulation. Unlike Orexin-A, Orexin-B exhibits receptor selectivity toward OXR2, making it a valuable tool for receptor-specific signaling studies. Preclinical research has investigated Orexin-B in the context of narcolepsy models, vigilance state regulation, autonomic modulation, and neuroendocrine signaling. Its receptor selectivity provides insight into differential orexin pathway activation in sleep and arousal research. FRESHLY PREPARED SOLUTION

Research indicates that Orexin-B is a neuropeptide involved in the regulation of wakefulness and arousal. It has been studied for its role in appetite-related signaling, locomotor activity, and modulation of sympathetic nervous system tone. Through its interactions with orexin receptors, Orexin-B contributes to neural pathways associated with vigilance, energy balance, and autonomic regulation.

Ovagen is a bioregulatory peptide that has been studied for its role in supporting gastrointestinal mucosal integrity and maintaining normal liver tissue structure. Research suggests it may help protect the gastrointestinal mucosal layer from stressors such as antibiotics, toxins, and anti-inflammatory agents, while also being associated with reduced fibrotic processes in liver tissue. Ongoing experimental studies are further evaluating Ovagen’s interaction with mechanisms involved in HIV viral replication. FRESHLY PREPARED SOLUTION 

Ovagen is a bioregulatory peptide that has been studied for its role in supporting gastrointestinal mucosal integrity and maintaining normal liver tissue structure. Research suggests it may help protect the gastrointestinal mucosal layer from stressors such as antibiotics, toxins, and anti-inflammatory agents, while also being associated with reduced fibrotic processes in liver tissue. Ongoing experimental studies are further evaluating Ovagen’s interaction with mechanisms involved in HIV viral replication.

Ovagen is a bioregulatory peptide that has been studied for its role in supporting gastrointestinal mucosal integrity and maintaining normal liver tissue structure. Research suggests it may help protect the gastrointestinal mucosal layer from stressors such as antibiotics, toxins, and anti-inflammatory agents, while also being associated with reduced fibrotic processes in liver tissue. Ongoing experimental studies are further evaluating Ovagen’s interaction with mechanisms involved in HIV viral replication.

Oxytocin is a multifunctional peptide hormone and neuropeptide involved in a wide range of physiological and psychological processes. Synthesized in the hypothalamus and released by the posterior pituitary gland, it acts both peripherally and within the central nervous system. Research has associated oxytocin with the following effects:Exhibits anti-inflammatory properties that support wound healing and tissue regenerationEnhances trust, empathy, and social recognition involved in interpersonal bondingImproves recognition of emotional expressions, supporting effective social communicationModulates neurotransmitter systems such as dopamine and serotonin, contributing to mood balance and stress reductionHas been investigated for potential roles in reducing symptoms associated with anxiety and depressive statesContributes to sexual receptivity and reproductive behaviors in both men and womenReduces activity of the amygdala, which is associated with fear and anxiety responsesInduces uterine contractions during labor and mediates milk ejection during breastfeeding

Oxytocin is a multifunctional peptide hormone and neuropeptide involved in a wide range of physiological and psychological processes. Synthesized in the hypothalamus and released by the posterior pituitary gland, it acts both peripherally and within the central nervous system. Research has associated oxytocin with the following effects: Exhibits anti-inflammatory properties that support wound healing and tissue regeneration Enhances trust, empathy, and social recognition involved in interpersonal bonding Improves recognition of emotional expressions, supporting effective social communication Modulates neurotransmitter systems such as dopamine and serotonin, contributing to mood balance and stress reduction Has been investigated for potential roles in reducing symptoms associated with anxiety and depressive states Contributes to sexual receptivity and reproductive behaviors in both men and women Reduces activity of the amygdala, which is associated with fear and anxiety responsesInduces uterine contractions during labor and mediates milk ejection during breastfeeding FRESHLY PREPARED SOLUTION 

Our Commitment to Analytical Transparency Whenever available, our third-party Certificates of Analysis (COAs) include: - HPLC purity testing - Mass Spectrometry (MS) identity confirmation - Net Peptide Content (NPC) analysis We believe that Net Peptide Content analysis is particularly important for evaluating the actual amount of peptide present, taking into account residual moisture, counterions, and other non-peptide components.Research indicates that P21 is associated with increased levels of brain-derived neurotrophic factor (BDNF), a key molecule involved in neuronal development and synaptic plasticity. BDNF is linked to enhanced neurogenesis and has been shown in experimental models to modulate biological pathways related to amyloid plaque and tau protein formation, both of which are characteristic features of Alzheimer’s disease pathology. In addition, multiple studies suggest that P21 supports learning processes and cognitive performance by promoting neuroplastic mechanisms and maintaining synaptic function in the central nervous system. FRESHLY PREPARED SOLUTION

INDEPENDENTLY TESTED • VERIFIED QUALITY ✓ Purity — HPLC analysis ✓ Identity — Mass spectrometry ✓ Net content  VERIFY COA AT FREEDOM DIAGNOSTICS → Enter search code: Suaw2605040576Research indicates that P21 is associated with increased levels of brain-derived neurotrophic factor (BDNF), a key molecule involved in neuronal development and synaptic plasticity. BDNF is linked to enhanced neurogenesis and has been shown in experimental models to modulate biological pathways related to amyloid plaque and tau protein formation, both of which are characteristic features of Alzheimer’s disease pathology. In addition, multiple studies suggest that P21 supports learning processes and cognitive performance by promoting neuroplastic mechanisms and maintaining synaptic function in the central nervous system.

PE-22-28 is a synthetic derivative of the naturally occurring peptide spadin that targets the TREK-1 channel. Since TREK-1 is found in brain regions that govern mood, memory, and learning, PE-22-28 was designed with the goal of being a potential treatment candidate for depression and a powerful stimulator of neurogenesis and synaptogenesis in the hippocampus. PE-22-28 is currently being researched for several applications, including: Antidepressant activity Enhancement of memory and learning Support for stroke recovery Potential roles in addressing neurodegenerative diseases such as Alzheimer’s Promotion of neurogenesis FRESHLY PREPARED SOLUTION

PE-22-28 is a synthetic derivative of the naturally occurring peptide spadin that targets the TREK-1 channel. Since TREK-1 is found in brain regions that govern mood, memory, and learning, PE-22-28 was designed with the goal of being a potential treatment candidate for depression and a powerful stimulator of neurogenesis and synaptogenesis in the hippocampus. PE-22-28 is currently being researched for several applications, including: Antidepressant activity Enhancement of memory and learning Support for stroke recovery Potential roles in addressing neurodegenerative diseases such as Alzheimer’s Promotion of neurogenesis

Pegylated Mechano Growth Factor (PEG-MGF) is a modified splice variant related to insulin-like growth factor-1    (IGF-1). In experimental research settings, PEG-MGF has been studied for its role in supporting myoblast division and facilitating the fusion and maturation of muscle fibers. Pegylation enhances the peptide’s stability and circulating half-life, allowing prolonged biological activity compared to non-pegylated MGF. Based on preclinical and experimental studies, PEG-MGF has been investigated in relation to the following biological processes: Support of muscle tissue remodeling Stimulation of new muscle cell formation Neuroprotective mechanisms in experimental models Cardioprotective pathways associated with cellular survival Processes involved in wound healing and tissue regeneration Bone repair and osteogenic activity in injury models Regulation of body fat metabolism and lipid-related markers Modulation of immune-related cellular responses

PHDP5 + TAT (44–57) is a synthetic peptide construct designed for advanced Alzheimer’s disease research, combining the PHDP5 sequence with a TAT cell-penetrating domain to enhance brain delivery and intracellular uptake. In preclinical Alzheimer’s disease models, PHDP5 has been reported to rescue learning and memory loss in Alzheimer’s disease, restoring cognitive performance to levels comparable to healthy controls. The mechanism is associated with inhibition of the pathological dynamin–microtubule interaction induced by tau, leading to recovery of synaptic vesicle endocytosis and neuronal communication. The addition of TAT (44–57) enables efficient penetration into brain tissue, including the hippocampus, following intranasal administration. While the peptide demonstrates strong effects on synaptic function and cognitive deficits in experimental Alzheimer’s models, its activity is primarily linked to tau-related dysfunction rather than direct amyloid plaque removal.

PHDP5 + TAT (44–57) is a synthetic peptide construct designed for advanced Alzheimer’s disease research, combining the PHDP5 sequence with a TAT cell-penetrating domain to enhance brain delivery and intracellular uptake. In preclinical Alzheimer’s disease models, PHDP5 has been reported to rescue learning and memory loss in Alzheimer’s disease, restoring cognitive performance to levels comparable to healthy controls. The mechanism is associated with inhibition of the pathological dynamin–microtubule interaction induced by tau, leading to recovery of synaptic vesicle endocytosis and neuronal communication. The addition of TAT (44–57) enables efficient penetration into brain tissue, including the hippocampus, following intranasal administration. While the peptide demonstrates strong effects on synaptic function and cognitive deficits in experimental Alzheimer’s models, its activity is primarily linked to tau-related dysfunction rather than direct amyloid plaque removal.

Most peptides exert their biological effects by interacting with cell surface or intracellular receptors. However, a limited number of peptides are capable of binding directly to DNA, thereby influencing fundamental biological processes at the level of gene regulation. Pinealon is one of these bioregulatory peptides. It has demonstrated neuroprotective properties and is considered a promising candidate for research focused on the modulation and management of various neurological conditions. Pinealon is known to affect the central nervous system by influencing behavior while also protecting neurons and other cell types from oxidative damage. One of the most notable characteristics of Pinealon is its ability to cross the cellular membrane, nuclear membrane, and the blood–brain barrier. This unique property helps explain its capacity to interact directly with DNA and regulate gene expression. Pinealon has been associated in research with potential applications including: Anti-aging effects Neuronal protection Modulation of depressive pathways Research into neurological disorders such as Alzheimer’s disease and Parkinson’s disease Memory enhancement Regulation of sleep and circadian rhythms

Most peptides exert their biological effects by interacting with cell surface or intracellular receptors. However, a limited number of peptides are capable of binding directly to DNA, thereby influencing fundamental biological processes at the level of gene regulation. Pinealon is one of these bioregulatory peptides. It has demonstrated neuroprotective properties and is considered a promising candidate for research focused on the modulation and management of various neurological conditions. Pinealon is known to affect the central nervous system by influencing behavior while also protecting neurons and other cell types from oxidative damage. One of the most notable characteristics of Pinealon is its ability to cross the cellular membrane, nuclear membrane, and the blood–brain barrier. This unique property helps explain its capacity to interact directly with DNA and regulate gene expression. Pinealon has been associated in research with potential applications including: Anti-aging effects Neuronal protection Modulation of depressive pathways Research into neurological disorders such as Alzheimer’s disease and Parkinson’s disease Memory enhancement Regulation of sleep and circadian rhythms FRESHLY PREPARED SOLUTION

PNC-27 is a synthetic research peptide studied for its selective activity against malignant cells. It is designed to bind to HDM-2, a protein that is abnormally expressed on the membranes of many cancer cells and is known to interact with the p53 tumor suppressor pathway. Experimental research indicates that PNC-27 can selectively induce cancer cell death by disrupting the integrity of the cancer cell membrane through a process known as membranolysis, while showing minimal interaction with non-cancerous cells.

PNC-28 is a synthetic peptide derived from the p53 protein, specifically from its MDM2-binding domain, and engineered with a penetratin sequence to enable efficient cellular uptake. It is studied for its ability to interact with dysregulated cellular pathways commonly found in transformed cells, particularly involving the MDM2 regulatory system. In experimental models, PNC-28 has been associated with the induction of non-apoptotic cell death mechanisms, characterized by loss of membrane integrity rather than classical programmed cell death. This feature makes it of particular interest in research settings where resistance to apoptosis is observed. Due to its unique mechanism and intracellular activity, PNC-28 is primarily used as a research tool in studies related to tumor biology, cellular stress responses, and alternative cell death pathways.

Prostamax is a prostate-derived bioregulatory peptide that has been investigated in experimental models of chronic aseptic prostate inflammation. Research data indicate that Prostamax is associated with a reduction in inflammatory markers, modulation of tissue remodeling processes, and prevention of fibrotic and atrophic changes within prostate tissue in animal-based studies. Additionally, experimental observations suggest an influence on functional activity parameters in studied models. Comparative research has shown that Prostamax demonstrates a broader and more sustained biological activity in prostate-focused experimental systems when compared with other commonly used prostatotropic research compounds of peptide origin.

Bremelanotide, also known as PT-141, is a synthetic peptide structurally related to alpha-MSH and melanocortin signaling molecules. It acts as an agonist of the MC3R and MC4R melanocortin receptors, which are involved in central nervous system pathways regulating motivation and arousal. By activating these receptors, PT-141 stimulates hypothalamic and related brain regions associated with sexual interest and behavioral response. Research indicates that its activity is centrally mediated rather than dependent on peripheral vascular mechanisms. While initially explored for sexual function in both men and women, scientific studies have shown particular relevance in premenopausal women experiencing conditions related to reduced sexual desire or arousal. According to research observations, PT-141 (Bremelanotide) has been associated with: Increased sexual desire and libido Higher frequency of sexual activity Support of erectile response in men with erectile dysfunction or impotence Potential benefit in premenopausal women with hypoactive sexual desire disorder Support in female sexual arousal–related dysfunctions Increased subjective energy and vitality levels

PTD-DBM + Valproic Acid is a research-oriented topical formulation designed to modulate intracellular signaling mechanisms associated with hair follicle biology. PTD-DBM (Protein Transduction Domain – Dishevelled Binding Motif) is a synthetic chimeric peptide developed to interfere with the inhibitory interaction between CXXC5 and Dishevelled (Dvl), a regulatory checkpoint within the Wnt/β-catenin signaling pathway. By reducing this inhibitory binding, PTD-DBM supports restoration of physiological Wnt pathway dynamics under experimental conditions. Valproic Acid (1.5%) acts as a complementary signaling modulator. Through inhibition of GSK3β and associated intracellular pathways, it contributes to β-catenin stabilization and supports downstream signaling activity. The combined formulation is structured to provide multi-layer modulation of follicular signaling networks, addressing both inhibitory feedback control (CXXC5–Dvl interaction) and β-catenin stabilization mechanisms. In preclinical research models, co-modulation of these pathways has been associated with: Enhanced dermal papilla signaling activity Promotion of anagen-associated markers Increased β-catenin pathway activity Support of follicular regenerative signaling dynamics FRESHLY PREPARED SOLUTION

QK is a synthetic peptide designed to mimic the activity of Vascular Endothelial Growth Factor (VEGF), one of the primary regulators of angiogenesis (the formation of new blood vessels). Unlike full-length VEGF, QK is a smaller and more stable molecule that retains the ability to bind endothelial receptors (particularly VEGFR-1), activating key biological pathways involved in vascular growth. Its primary effect is the stimulation of angiogenesis, through: endothelial cell proliferation and migration formation of new capillary structures improvement of microcirculation These properties make QK highly relevant in research related to: tissue regeneration wound healing ischemic conditions (reduced blood flow) endothelial function and vascular health In summary, QK is a targeted angiogenic mimetic, useful for studying controlled vascular growth in experimental settings, offering improved stability and control compared to natural VEGF.